Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INF-BEAST2 long-term follow-up of thrombophilia and cardiovascular markers in HIV patients on cART
NL-OMON47997Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial in Human immunodeficiency virus infection type 1, sponsored by University Medical Center Groningen. Primary endpoints: Antithrombin plasma level, Protein C antigen plasma level and 6 more. Started Jul 2019; status: active, not recruiting.
02
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on NL-OMON47997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47997.